Skip to main content
. Author manuscript; available in PMC: 2021 Jul 21.
Published in final edited form as: Chem Res Toxicol. 2020 Apr 14;33(5):1121–1144. doi: 10.1021/acs.chemrestox.0c00050

Figure 1.

Figure 1.

A schematic overview representing exposure to nanomaterials/ -particles (1), aggregated across sources and over time, their absorption and distribution in the body (2), and accumulated outcomes from exposure accumulated across materials and over time at the cellular, organ (3) and individual or population level (4).